» Articles » PMID: 113458

A New Mouse Myeloma Cell Line That Has Lost Immunoglobulin Expression but Permits the Construction of Antibody-secreting Hybrid Cell Lines

Overview
Journal J Immunol
Date 1979 Oct 1
PMID 113458
Citations 475
Authors
Affiliations
Soon will be listed here.
Abstract

We have isolated a subclone of the mouse myeloma cell line P3-X63-Ag8 that does not express immunoglobulin heavy or light chains. This clone X63-Ag8.653 can be used for efficient fusion with antibody-forming cells to obtain hybrid cell lines producing pure monoclonal antibodies. Screening of hybrid cell lines for specificity and immunoglobulin classes was done with a modified enzyme-linked immunosorbent assay.

Citing Articles

Neonatal and maternal upregulation of antileukoproteinase in horses.

Holmes C, Babasyan S, Wagner B Front Immunol. 2024; 15:1395030.

PMID: 38736885 PMC: 11082313. DOI: 10.3389/fimmu.2024.1395030.


Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain.

Anzai I, Fujita J, Ono C, Kosaka Y, Miyamoto Y, Shichinohe S Microbiol Spectr. 2024; 12(4):e0365523.

PMID: 38415660 PMC: 10986471. DOI: 10.1128/spectrum.03655-23.


Methods for Engineering Binders to Multi-Pass Membrane Proteins.

Thomas B, Chockalingam K, Chen Z Bioengineering (Basel). 2023; 10(12).

PMID: 38135942 PMC: 10741020. DOI: 10.3390/bioengineering10121351.


tANCHOR fast and cost-effective cell-based immunization approach with focus on the receptor-binding domain of SARS-CoV-2.

Bernauer H, Schlor A, Maier J, Bannert N, Hanack K, Ivanusic D Biol Methods Protoc. 2023; 8(1):bpad030.

PMID: 38090673 PMC: 10713279. DOI: 10.1093/biomethods/bpad030.


Identification of miR-128 Target mRNAs That Are Expressed in B Cells Using a Modified Dual Luciferase Vector.

Schreiber S, Daum P, Danzer H, Hauke M, Jack H, Wittmann J Biomolecules. 2023; 13(10).

PMID: 37892199 PMC: 10605364. DOI: 10.3390/biom13101517.